EA200801797A2 - Способ получения эсциталопрама - Google Patents

Способ получения эсциталопрама

Info

Publication number
EA200801797A2
EA200801797A2 EA200801797A EA200801797A EA200801797A2 EA 200801797 A2 EA200801797 A2 EA 200801797A2 EA 200801797 A EA200801797 A EA 200801797A EA 200801797 A EA200801797 A EA 200801797A EA 200801797 A2 EA200801797 A2 EA 200801797A2
Authority
EA
Eurasian Patent Office
Prior art keywords
escitaloprama
obtaining
benzonitrile
hydroxybutyl
fluorophenyl
Prior art date
Application number
EA200801797A
Other languages
English (en)
Other versions
EA012787B1 (ru
EA200801797A3 (ru
Inventor
Карла Де Фавери
Флориан Антон Мартин Хубер
Роберт Джеймс Дансер
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200801797(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200801797A2 publication Critical patent/EA200801797A2/ru
Publication of EA200801797A3 publication Critical patent/EA200801797A3/ru
Publication of EA012787B1 publication Critical patent/EA012787B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton

Abstract

В заявке раскрыт способ разделения 4-[4-(диметиламино)-1-(4'-фторфенил)-1-гидроксибутил]-3-(гидроксиметил)бензонитрила как рацемической или нерацемической смеси энантиомеров на отдельные энантиомеры, включающий стадию фракционной кристаллизации 4-[4-(диметиламино)-1-(4'-фторфенил)-1-гидроксибутил]-3-(гидроксиметил)бензонитрила в форме соли с (+)-(S,S)- или (-)-(R,R)-энантиомером О,О'-ди-п-толуол-винной кислоты в системе растворителей, включающей 1-пропанол, этанол или ацетонитрил.
EA200801797A 2007-09-11 2008-09-02 Способ получения эсциталопрама EA012787B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200701314 2007-09-11

Publications (3)

Publication Number Publication Date
EA200801797A2 true EA200801797A2 (ru) 2008-12-30
EA200801797A3 EA200801797A3 (ru) 2009-02-27
EA012787B1 EA012787B1 (ru) 2009-12-30

Family

ID=39735675

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801797A EA012787B1 (ru) 2007-09-11 2008-09-02 Способ получения эсциталопрама

Country Status (52)

Country Link
EP (2) EP2397461A1 (ru)
JP (1) JP4966933B2 (ru)
KR (1) KR101054224B1 (ru)
CN (1) CN101386583A (ru)
AR (2) AR068174A1 (ru)
AT (2) ATE518829T1 (ru)
AU (1) AU2008212055C1 (ru)
BE (1) BE1017548A6 (ru)
BG (1) BG110206A (ru)
BR (1) BRPI0804121B1 (ru)
CA (1) CA2638499C (ru)
CH (1) CH697885B1 (ru)
CL (1) CL2008002686A1 (ru)
CO (1) CO6140012A1 (ru)
CY (2) CY2600B1 (ru)
CZ (1) CZ2008537A3 (ru)
DE (1) DE102008046530A1 (ru)
DK (2) DK2061753T3 (ru)
EA (1) EA012787B1 (ru)
EE (1) EE00864U1 (ru)
ES (2) ES2368294T3 (ru)
FI (1) FI121570B (ru)
FR (1) FR2920766A1 (ru)
GB (1) GB2448848B (ru)
GR (1) GR1006595B (ru)
HR (2) HRP20080425A2 (ru)
HU (1) HUP0800549A2 (ru)
IE (1) IES20080708A2 (ru)
IL (1) IL193845A (ru)
IS (1) IS8758A (ru)
LT (1) LT5577B (ru)
LU (1) LU91479B1 (ru)
LV (1) LV13813B (ru)
ME (1) ME00176B (ru)
MX (1) MX2008011451A (ru)
MY (1) MY144210A (ru)
NL (1) NL2001953C2 (ru)
NO (1) NO20083756L (ru)
NZ (1) NZ570884A (ru)
PL (2) PL386026A1 (ru)
PT (2) PT104169A (ru)
RO (1) RO125301A2 (ru)
RS (2) RS20080401A (ru)
SE (1) SE533041C2 (ru)
SG (1) SG151195A1 (ru)
SI (2) SI22567A2 (ru)
SK (1) SK500302008A3 (ru)
TR (2) TR200806903A2 (ru)
TW (1) TWI391383B (ru)
UA (2) UA41919U (ru)
WO (1) WO2009033488A1 (ru)
ZA (1) ZA200807753B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007012954A1 (en) 2005-07-27 2007-02-01 Aurobindo Pharma Limited An improved process for the preparation of escitalopram
CN102796065A (zh) * 2011-05-27 2012-11-28 江苏豪森医药集团连云港宏创医药有限公司 一种制备光学纯度高的艾司西酞普兰的方法
CN104119240A (zh) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 (S)-(-)-α-甲胺基苯丙酮的制备方法
CN103497145B (zh) * 2013-10-10 2016-01-27 南昌大学 一种光学纯多奈哌齐的制备工艺
CN104119248A (zh) * 2014-08-08 2014-10-29 广东东阳光药业有限公司 S-西酞普兰的制备方法
US10287240B2 (en) 2014-11-14 2019-05-14 Zhejiang Hushai Pharmaceuticals Co., Ltd. Method for resolution of citalopram intermediate 5-cyano diol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
CA2511143C (en) 2002-12-23 2011-06-28 H. Lundbeck A/S Preparation of racemic and/or s- or r-citalopram diols and their use for the preparation racemic and/or s- or r-citalopram
WO2004065375A1 (en) * 2003-01-17 2004-08-05 Natco Pharma Limited Processes for the preparation of escitalopram and its precursor
WO2005047274A1 (en) * 2003-11-12 2005-05-26 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
WO2006106531A1 (en) * 2005-04-04 2006-10-12 Jubilant Organosys Ltd Process for the preparation of escitalopram or its acid addition salts
WO2007012954A1 (en) * 2005-07-27 2007-02-01 Aurobindo Pharma Limited An improved process for the preparation of escitalopram

Also Published As

Publication number Publication date
SI22567A2 (sl) 2008-12-31
ES2334875A1 (es) 2010-03-16
HRP20110636T1 (hr) 2011-10-31
PT2061753E (pt) 2011-09-14
RS20080401A (en) 2010-03-02
PT104169A (pt) 2009-02-02
RO125301A2 (ro) 2010-03-30
ZA200807753B (en) 2009-04-29
FI20085807A (fi) 2009-03-12
AT10984U1 (de) 2010-02-15
KR101054224B1 (ko) 2011-08-08
EP2397461A1 (en) 2011-12-21
EP2061753A1 (en) 2009-05-27
GR20080100581A (el) 2009-04-30
TR200806903A2 (tr) 2009-03-23
DK2061753T3 (da) 2011-09-26
LT2008068A (en) 2009-03-25
LT5577B (lt) 2009-06-25
JP2009149600A (ja) 2009-07-09
RS51909B (en) 2012-02-29
FI20085807A0 (fi) 2008-08-29
SI2061753T1 (sl) 2011-10-28
BRPI0804121A8 (pt) 2021-04-13
GB0815773D0 (en) 2008-10-08
MEP10108A (en) 2010-10-10
CZ2008537A3 (cs) 2009-03-18
GB2448848B (en) 2011-01-26
CA2638499C (en) 2010-09-28
TW200906814A (en) 2009-02-16
WO2009033488A1 (en) 2009-03-19
BG110206A (en) 2009-03-31
HU0800549D0 (en) 2008-10-28
MY144210A (en) 2011-08-15
JP4966933B2 (ja) 2012-07-04
GR1006595B (el) 2009-11-16
NL2001953A1 (nl) 2008-12-22
AR108885A2 (es) 2018-10-03
NZ570884A (en) 2010-03-26
UA41919U (ru) 2009-06-10
IES20080708A2 (en) 2009-03-18
HUP0800549A2 (en) 2009-03-02
AR068174A1 (es) 2009-11-11
GB2448848A (en) 2008-10-29
ES2368294T3 (es) 2011-11-16
EP2061753B1 (en) 2011-08-03
LU91479B1 (fr) 2010-03-11
SG151195A1 (en) 2009-04-30
AU2008212055C1 (en) 2011-06-02
DK200801265A (en) 2009-03-12
AU2008212055A1 (en) 2009-03-26
PL386026A1 (pl) 2009-02-16
CA2638499A1 (en) 2008-11-21
PL2061753T3 (pl) 2011-12-30
EE00864U1 (et) 2009-10-15
SE533041C2 (sv) 2010-06-15
AU2008212055B2 (en) 2010-08-12
ME00176B (me) 2011-02-10
SE0801929L (sv) 2009-03-12
ATE518829T1 (de) 2011-08-15
NO20083756L (no) 2009-03-12
EA012787B1 (ru) 2009-12-30
LV13813B (en) 2008-11-20
EA200801797A3 (ru) 2009-02-27
HRP20080425A2 (hr) 2010-04-30
IS8758A (is) 2009-03-12
CO6140012A1 (es) 2010-03-19
CY2600B1 (en) 2010-03-03
BRPI0804121B1 (pt) 2022-04-12
ES2334875B1 (es) 2010-10-27
CN101386583A (zh) 2009-03-18
IL193845A (en) 2011-03-31
DE102008046530A1 (de) 2009-03-19
BE1017548A6 (fr) 2008-11-04
DK177075B1 (da) 2011-06-14
CL2008002686A1 (es) 2009-01-02
TWI391383B (zh) 2013-04-01
TR200907629A2 (tr) 2009-11-23
SK500302008A3 (sk) 2009-04-06
NL2001953C2 (en) 2009-05-07
KR20090027185A (ko) 2009-03-16
CY1111924T1 (el) 2015-11-04
UA43461U (ru) 2009-08-25
BRPI0804121A2 (pt) 2009-09-29
MX2008011451A (es) 2009-03-10
FR2920766A1 (fr) 2009-03-13
FI121570B (fi) 2011-01-14
CH697885B1 (de) 2009-03-13

Similar Documents

Publication Publication Date Title
EA200801797A3 (ru) Способ получения эсциталопрама
FI3710437T3 (fi) Raseeemisen nikotiinin enantiomeerinen erotus lisäämällä optiselta puhtaudeltaan alhaista o,o'-disubstituoidun viinihapon enantiomeeriä
EA201891437A1 (ru) Способ разделения энантиомеров пиперазиновых производных
EP3950681A3 (en) Salts and solid forms of the compound (s)-3-(4-((4-morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
ATE449096T1 (de) Verfahren zur herstellung von 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-p enoxypropyl)-1- azoniabicycloä2.2.2üoctanbromid
DK1812385T3 (da) Fremgangsmåde til fremstilling af enantiomere af amidoacetonitrilforbindelser ud fra deres racemater
EA200801507A1 (ru) Оптически активные карбаматы, способ их получения и их применение в качестве фармацевтических промежуточных соединений
ATE327972T1 (de) Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin
ATE526312T1 (de) Verfahren zur herstellung von reinen 4- pyrrolidinophenylbenzyletherderivaten als maob- inhibitoren
DK1794152T3 (da) Fremgangsmåde til fremstilling af enantiomeriske imidazol-forbindelser
DE602004022337D1 (de) Verfahren zur herstellung von pyridinylmethyl-1h-benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
MX2022002568A (es) Proceso para preparar (r)-4-aminoindano y amidas correspondientes.
DE602004030571D1 (de) Verfahren zur herstellung optisch aktiven 1-alkyl-substituierter 2,2,2-trifluorethylamins
ATE415388T1 (de) Verfahren zur herstellung von enantiomerenreinen 4-pyrrolidinophenyl- benzyletherderivaten
DE502005003019D1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten
ATE534639T1 (de) Verfahren zur lösung von citalopram
ATE543820T1 (de) Verfahren zur herstellung von 2,3,4,9-tetrahydro- 1h-beta-carbolin-3-carbonsäureestern
DE602007010926D1 (de) Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol
WO2006127331A3 (en) Conversion process for 2,3-benzodiazepine enantiomers
ATE442132T1 (de) Verfahren zur herstellung von glimepirid enthaltenden pharmazeutischen zusammensetzungen
HRP20040639A2 (en) Preparation of enantiomer pure (r or s)-2-[2- ethoxymethyl]-3-ethoxycarbonyl-4-(2-chlorphenyl)-5- by separation of racemate in chiral inactive phases
ATE421953T1 (de) Verfahren zur racemisierung von 1-benzyl-4-(4- fluorophenyl)-3-hydroxymethyl-1,2,3,6- tetrahydropyridin und dessen verwendung in der synthese von paroxetin

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM